Clinical Trial Update: p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of p53 gene therapy (Gendicine/Ad-p53) for advanced head and neck cancers by Shenzhen SiBiono GeneTech; the trial status is UNKNOW…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Gendicine (recombinant adenovirus p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Neoplasms | Phase 4 | Status: UNKNOWN